Emerging evidence has testified that M1 mAChR is widely expressed in the central nervous system and activation of M1 muscarinic receptors may influence the occurrence or development of AD via coupling to Gq and activating PLCβ and PKC [20,21]. This evidence concerns the gene PRRT2 and Alzheimer disease.